BR0206272A - Forma de dosagem unitária sólida compreendendo citalopram - Google Patents

Forma de dosagem unitária sólida compreendendo citalopram

Info

Publication number
BR0206272A
BR0206272A BR0206272-0A BR0206272A BR0206272A BR 0206272 A BR0206272 A BR 0206272A BR 0206272 A BR0206272 A BR 0206272A BR 0206272 A BR0206272 A BR 0206272A
Authority
BR
Brazil
Prior art keywords
citalopram
dosage form
unit dosage
solid unit
pharmaceutically acceptable
Prior art date
Application number
BR0206272-0A
Other languages
English (en)
Inventor
Ken Liljegren
Per Holm
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BR0206272A publication Critical patent/BR0206272A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"FORMA DE DOSAGEM UNITáRIA SóLIDA COMPREENDENDO CITALOPRAM". Uma forma de dosagem unitária sólida compreendendo citalopram que é preparada por um processo compreendendo uma etapa na qual base de citalopram ou um sal farmaceuticamente aceitável e opcionalmente excipientes farmaceuticamente aceitáveis é compactada por rolo.
BR0206272-0A 2001-01-05 2002-01-03 Forma de dosagem unitária sólida compreendendo citalopram BR0206272A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100016 2001-01-05
PCT/DK2002/000003 WO2002053133A1 (en) 2001-01-05 2002-01-03 Pharmaceutical composition containing citalopram

Publications (1)

Publication Number Publication Date
BR0206272A true BR0206272A (pt) 2003-12-30

Family

ID=8159961

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0206272-0A BR0206272A (pt) 2001-01-05 2002-01-03 Forma de dosagem unitária sólida compreendendo citalopram

Country Status (22)

Country Link
US (1) US20040058989A1 (pt)
EP (1) EP1351667A1 (pt)
JP (1) JP2004517111A (pt)
KR (1) KR20030070088A (pt)
CN (1) CN1484523A (pt)
AU (1) AU2001100195B4 (pt)
BG (1) BG108034A (pt)
BR (1) BR0206272A (pt)
CA (1) CA2358356A1 (pt)
CZ (1) CZ20032119A3 (pt)
EA (1) EA005596B1 (pt)
HR (1) HRP20030546A2 (pt)
HU (1) HUP0302531A3 (pt)
IL (1) IL156547A0 (pt)
IS (1) IS6857A (pt)
MX (1) MXPA03005965A (pt)
NO (1) NO20033073D0 (pt)
PL (1) PL362358A1 (pt)
SK (1) SK9912003A3 (pt)
WO (1) WO2002053133A1 (pt)
YU (1) YU54503A (pt)
ZA (1) ZA200304860B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
AU2004222339A1 (en) * 2003-03-14 2004-09-30 Nirmal Mulye A process for preparing sustained release tablets
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006123243A2 (en) * 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
NO20033073L (no) 2003-07-04
EA200300768A1 (ru) 2003-10-30
HUP0302531A3 (en) 2007-06-28
PL362358A1 (en) 2004-10-18
IL156547A0 (en) 2004-01-04
CA2358356A1 (en) 2002-01-20
AU2001100195A4 (en) 2001-08-16
WO2002053133A1 (en) 2002-07-11
AU2001100195B4 (en) 2001-12-20
HRP20030546A2 (en) 2005-06-30
EP1351667A1 (en) 2003-10-15
US20040058989A1 (en) 2004-03-25
CN1484523A (zh) 2004-03-24
HUP0302531A2 (hu) 2003-11-28
ZA200304860B (en) 2004-06-30
BG108034A (bg) 2005-02-28
KR20030070088A (ko) 2003-08-27
SK9912003A3 (en) 2003-12-02
CZ20032119A3 (en) 2004-03-17
EA005596B1 (ru) 2005-04-28
IS6857A (is) 2003-06-23
YU54503A (sh) 2006-05-25
NO20033073D0 (no) 2003-07-04
JP2004517111A (ja) 2004-06-10
MXPA03005965A (es) 2003-09-05

Similar Documents

Publication Publication Date Title
NO2020019I1 (no) Maraviroc eventuelt i form av et farmasøytisk akseptabelt salt
EE200200716A (et) Ühendid Alzheimeri tõve käitluseks
GEP20074047B (en) Pramipexole once-daily dosage form
AU2001273132A1 (en) Compounds to treat alzheimer's disease
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
DE60142197D1 (de) Pharmazeutische Zusammensetzung
AU2001249329A1 (en) Lipoxin analogs and methods for the treatment of periodontal disease
WO2002042462A3 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
EA200301223A1 (ru) Лекарственные формы окскарбазепина
NO20022645D0 (no) Farmasöytisk superdisintegrerende stoff
TR200400228T4 (tr) Psöryazinin tedavisinde kullanılacak maddeler
DE60102590T2 (de) Darreichungsformen zur behandlung von oralen mykosen
ATE392214T1 (de) Impfstoff gegen geschlechtlich übertragene krankheiten
DK0966277T3 (da) Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom
BR0206272A (pt) Forma de dosagem unitária sólida compreendendo citalopram
ATE366128T1 (de) Pharmazeutische zusammensetzung
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
BR0113250A (pt) Forma de unidade de dosagem sólida; cristais de um sal de citalopram farmaceuticamente aceitável e método para fabricação dos referidos cristais
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
BR0210632A (pt) Tratamento de doença parasìtica
YU87501A (sh) Farmaceutski kompleksi
ITTO20000441A0 (it) Composizione terapeutica per la cura della psoriasi.
BR0112025A (pt) Prótese dentária, processo para sua fabricação e uso da mesma
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A A NUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010.